Endosomal Toll-Like Receptor Status in Patients with Metabolic Syndrome

Sridevi Devaraj, Beverley Adams-Huet, Ishwarlal Jialal

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Metabolic syndrome (MetS) predisposes to both diabetes and cardiovascular disease, and inflammation is pivotal in MetS. The Toll-like receptors (TLRs), TLR2 and TLR4, are implicated in both diabetes and atherosclerosis, are increased in MetS, and contribute to the inflammatory burden. Recent studies also suggest an evolving role of endosomal TLRs in diabetic complications. However, there is a paucity of data with regard to the expression of endosomal TLRs such as TLR3, 7-9 in MetS. Aim: Thus, in this short report, we examine expression of monocytes TLR3 and TLR9 in our cohort of subjects with nascent MetS compared to matched controls. Subjects and Methods: Monocytes were isolated from subjects with MetS (n=45) and matched controls (n=37), respectively, and TLR3 and TLR9 expression was assessed by intracellular flow cytometry and correlated with nuclear factor (NF)-κB expression. Results: We demonstrate increased endosomal TLR9 expression in MetS compared to controls that correlate with increased nuclear NF-κB expression in the monocytes of these subjects, with no change in TLR3 protein. Conclusion: Future studies are required to confirm these findings and determine the role of TLR9 in the increased cardiovascular risk in MetS.

Original languageEnglish (US)
Pages (from-to)477-480
Number of pages4
JournalMetabolic Syndrome and Related Disorders
Volume13
Issue number10
DOIs
StatePublished - Dec 1 2015

Fingerprint

Toll-Like Receptors
Monocytes
Diabetes Complications
Atherosclerosis
Flow Cytometry
Cardiovascular Diseases
Inflammation

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

Endosomal Toll-Like Receptor Status in Patients with Metabolic Syndrome. / Devaraj, Sridevi; Adams-Huet, Beverley; Jialal, Ishwarlal.

In: Metabolic Syndrome and Related Disorders, Vol. 13, No. 10, 01.12.2015, p. 477-480.

Research output: Contribution to journalArticle

Devaraj, Sridevi ; Adams-Huet, Beverley ; Jialal, Ishwarlal. / Endosomal Toll-Like Receptor Status in Patients with Metabolic Syndrome. In: Metabolic Syndrome and Related Disorders. 2015 ; Vol. 13, No. 10. pp. 477-480.
@article{9f988b73ebe74ff8815f83a6ad5e06ce,
title = "Endosomal Toll-Like Receptor Status in Patients with Metabolic Syndrome",
abstract = "Background: Metabolic syndrome (MetS) predisposes to both diabetes and cardiovascular disease, and inflammation is pivotal in MetS. The Toll-like receptors (TLRs), TLR2 and TLR4, are implicated in both diabetes and atherosclerosis, are increased in MetS, and contribute to the inflammatory burden. Recent studies also suggest an evolving role of endosomal TLRs in diabetic complications. However, there is a paucity of data with regard to the expression of endosomal TLRs such as TLR3, 7-9 in MetS. Aim: Thus, in this short report, we examine expression of monocytes TLR3 and TLR9 in our cohort of subjects with nascent MetS compared to matched controls. Subjects and Methods: Monocytes were isolated from subjects with MetS (n=45) and matched controls (n=37), respectively, and TLR3 and TLR9 expression was assessed by intracellular flow cytometry and correlated with nuclear factor (NF)-κB expression. Results: We demonstrate increased endosomal TLR9 expression in MetS compared to controls that correlate with increased nuclear NF-κB expression in the monocytes of these subjects, with no change in TLR3 protein. Conclusion: Future studies are required to confirm these findings and determine the role of TLR9 in the increased cardiovascular risk in MetS.",
author = "Sridevi Devaraj and Beverley Adams-Huet and Ishwarlal Jialal",
year = "2015",
month = "12",
day = "1",
doi = "10.1089/met.2015.0116",
language = "English (US)",
volume = "13",
pages = "477--480",
journal = "Metabolic Syndrome and Related Disorders",
issn = "1540-4196",
publisher = "Mary Ann Liebert Inc.",
number = "10",

}

TY - JOUR

T1 - Endosomal Toll-Like Receptor Status in Patients with Metabolic Syndrome

AU - Devaraj, Sridevi

AU - Adams-Huet, Beverley

AU - Jialal, Ishwarlal

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Background: Metabolic syndrome (MetS) predisposes to both diabetes and cardiovascular disease, and inflammation is pivotal in MetS. The Toll-like receptors (TLRs), TLR2 and TLR4, are implicated in both diabetes and atherosclerosis, are increased in MetS, and contribute to the inflammatory burden. Recent studies also suggest an evolving role of endosomal TLRs in diabetic complications. However, there is a paucity of data with regard to the expression of endosomal TLRs such as TLR3, 7-9 in MetS. Aim: Thus, in this short report, we examine expression of monocytes TLR3 and TLR9 in our cohort of subjects with nascent MetS compared to matched controls. Subjects and Methods: Monocytes were isolated from subjects with MetS (n=45) and matched controls (n=37), respectively, and TLR3 and TLR9 expression was assessed by intracellular flow cytometry and correlated with nuclear factor (NF)-κB expression. Results: We demonstrate increased endosomal TLR9 expression in MetS compared to controls that correlate with increased nuclear NF-κB expression in the monocytes of these subjects, with no change in TLR3 protein. Conclusion: Future studies are required to confirm these findings and determine the role of TLR9 in the increased cardiovascular risk in MetS.

AB - Background: Metabolic syndrome (MetS) predisposes to both diabetes and cardiovascular disease, and inflammation is pivotal in MetS. The Toll-like receptors (TLRs), TLR2 and TLR4, are implicated in both diabetes and atherosclerosis, are increased in MetS, and contribute to the inflammatory burden. Recent studies also suggest an evolving role of endosomal TLRs in diabetic complications. However, there is a paucity of data with regard to the expression of endosomal TLRs such as TLR3, 7-9 in MetS. Aim: Thus, in this short report, we examine expression of monocytes TLR3 and TLR9 in our cohort of subjects with nascent MetS compared to matched controls. Subjects and Methods: Monocytes were isolated from subjects with MetS (n=45) and matched controls (n=37), respectively, and TLR3 and TLR9 expression was assessed by intracellular flow cytometry and correlated with nuclear factor (NF)-κB expression. Results: We demonstrate increased endosomal TLR9 expression in MetS compared to controls that correlate with increased nuclear NF-κB expression in the monocytes of these subjects, with no change in TLR3 protein. Conclusion: Future studies are required to confirm these findings and determine the role of TLR9 in the increased cardiovascular risk in MetS.

UR - http://www.scopus.com/inward/record.url?scp=84947273772&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947273772&partnerID=8YFLogxK

U2 - 10.1089/met.2015.0116

DO - 10.1089/met.2015.0116

M3 - Article

VL - 13

SP - 477

EP - 480

JO - Metabolic Syndrome and Related Disorders

JF - Metabolic Syndrome and Related Disorders

SN - 1540-4196

IS - 10

ER -